These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 38890346)
1. Identification of a novel monocyte/macrophage-related gene signature for predicting survival and immune response in acute myeloid leukemia. Zhan Y; Ma S; Zhang T; Zhang L; Zhao P; Yang X; Liu M; Cheng W; Li Y; Wang J Sci Rep; 2024 Jun; 14(1):14012. PubMed ID: 38890346 [TBL] [Abstract][Full Text] [Related]
2. Lysosome-related genes predict acute myeloid leukemia prognosis and response to immunotherapy. Wan P; Zhong L; Yu L; Shen C; Shao X; Chen S; Zhou Z; Wang M; Zhang H; Liu B Front Immunol; 2024; 15():1384633. PubMed ID: 38799454 [TBL] [Abstract][Full Text] [Related]
3. NAD metabolism-related genes provide prognostic value and potential therapeutic insights for acute myeloid leukemia. Cao Y; Shu W; Jin P; Li J; Zhu H; Chen X; Zhu Y; Huang X; Cheng W; Shen Y Front Immunol; 2024; 15():1417398. PubMed ID: 38966636 [TBL] [Abstract][Full Text] [Related]
4. Immune-related gene signature predicts clinical outcomes and immunotherapy response in acute myeloid leukemia. Xu Q; Cao D; Fang B; Yan S; Hu Y; Guo T Cancer Med; 2022 Sep; 11(17):3364-3380. PubMed ID: 35355427 [TBL] [Abstract][Full Text] [Related]
5. Prognostic role of chemokine-related genes in acute myeloid leukemia. Hou Y; Chen Y; Zhang Y; Li M; Chen J PeerJ; 2024; 12():e17862. PubMed ID: 39135956 [TBL] [Abstract][Full Text] [Related]
6. Construction and validation of a SASP-related prognostic signature in patients with acute myeloid leukaemia. Li MF; Zhang DH; Wang LS; Yue CF; Pang LJ; Guo YM; Yang ZG J Cell Mol Med; 2024 Aug; 28(16):e70017. PubMed ID: 39159071 [TBL] [Abstract][Full Text] [Related]
7. Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature. Fu D; Zhang B; Wu S; Zhang Y; Xie J; Ning W; Jiang H Front Immunol; 2021; 12():695865. PubMed ID: 34135913 [TBL] [Abstract][Full Text] [Related]
8. A CD8 Li Z; Jin P; Xiang R; Li X; Shen J; He M; Liu X; Zhu H; Wu S; Dong F; Zhao H; Liu H; Jin Z; Li J Front Immunol; 2024; 15():1408109. PubMed ID: 39346926 [TBL] [Abstract][Full Text] [Related]
9. Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia. Wang J; Hao JP; Uddin MN; Wu Y; Chen R; Li DF; Xiong DQ; Ding N; Yang JH; Ding XS Aging (Albany NY); 2021 Jun; 13(12):16445-16470. PubMed ID: 34148032 [TBL] [Abstract][Full Text] [Related]
10. HCK is a Potential Prognostic Biomarker that Correlates with Immune Cell Infiltration in Acute Myeloid Leukemia. Cheng F; Li Q; Wang J; Wang L; Li W; Zeng F Dis Markers; 2022; 2022():3199589. PubMed ID: 35280440 [TBL] [Abstract][Full Text] [Related]
11. High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia. Li K; Chen L; Zhang H; Wang L; Sha K; Du X; Li D; Zheng Z; Pei R; Lu Y; Tong H Aging (Albany NY); 2021 Apr; 13(8):11988-12006. PubMed ID: 33891561 [TBL] [Abstract][Full Text] [Related]
12. Identification of the Integrated Prognostic Signature Associated with Immuno-relevant Genes and Long Non-coding RNAs in Acute Myeloid Leukemia. Zhao C; Wang Y; Sharma A; Wang Z; Zheng C; Wei Y; Wu Y; Liu P; Liu J; Zhan X; Schmidt-Wolf I; Tu F Cancer Invest; 2022 Sep; 40(8):663-674. PubMed ID: 35770858 [TBL] [Abstract][Full Text] [Related]
13. GPX1-associated prognostic signature predicts poor survival in patients with acute myeloid leukemia and involves in immunosuppression. Zhang J; Peng Y; He Y; Xiao Y; Wang Q; Zhao Y; Zhang T; Wu C; Xie Y; Zhou J; Yu W; Lu D; Bai H; Chen T; Guo P; Zhang Q Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166268. PubMed ID: 34536536 [TBL] [Abstract][Full Text] [Related]
14. Construction of prognostic risk prediction model based on high-throughput sequencing expression profile data in childhood acute myeloid leukemia. Niu P; Yao B; Wei L; Zhu H; Fang C; Zhao Y Blood Cells Mol Dis; 2019 Jul; 77():43-50. PubMed ID: 30954792 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive characterization of immunogenic cell death in acute myeloid leukemia revealing the association with prognosis and tumor immune microenvironment. Chen Y; Qiu X; Liu R BMC Med Genomics; 2024 Apr; 17(1):107. PubMed ID: 38671491 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive DNA repair gene expression analysis and its prognostic significance in acute myeloid leukemia. Park S; Kim YJ; Huh HJ; Chung HS; Lee M; Park YM; Mun YC; Seong CM; Huh J Hematology; 2021 Dec; 26(1):904-913. PubMed ID: 34789078 [TBL] [Abstract][Full Text] [Related]
17. A transient receptor potential channel-related model based on machine learning for evaluating tumor microenvironment and immunotherapeutic strategies in acute myeloid leukemia. Hua J; Ding T; Shao Y Front Immunol; 2022; 13():1040661. PubMed ID: 36591215 [TBL] [Abstract][Full Text] [Related]
18. A hypoxia risk signature for the tumor immune microenvironment evaluation and prognosis prediction in acute myeloid leukemia. Jiang F; Mao Y; Lu B; Zhou G; Wang J Sci Rep; 2021 Jul; 11(1):14657. PubMed ID: 34282207 [TBL] [Abstract][Full Text] [Related]
19. Development and validation of a promising 5-gene prognostic model for pediatric acute myeloid leukemia. Tao Y; Wei L; Shiba N; Tomizawa D; Hayashi Y; Ogawa S; Chen L; You H Mol Biomed; 2024 Jan; 5(1):1. PubMed ID: 38163849 [TBL] [Abstract][Full Text] [Related]
20. A three-gene signature might predict prognosis in patients with acute myeloid leukemia. Zhu X; Zhao Q; Su X; Ke J; Yi Y; Yi J; Lin J; Qian J; Deng Z Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32436945 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]